Skip to main content
Erschienen in: Journal of Neurology 7/2017

26.06.2017 | Original Communication

Lateralized microstructural changes in early-stage Parkinson’s disease in anterior olfactory structures, but not in substantia nigra

verfasst von: N. Joshi, T. M. Rolheiser, J. D. Fisk, J. R. McKelvey, K. Schoffer, G. Phillips, M. Armstrong, M. N. Khan, R. A. Leslie, B. Rusak, H. A. Robertson, K. P. Good

Erschienen in: Journal of Neurology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Parkinson’s disease (PD) is a progressive neurological disorder characterized by motor symptoms as well as severe deficits in olfactory function and microstructural changes in olfactory brain regions. Because of the evidence of asymmetric neuropathological features in early-stage PD, we examined whether lateralized microstructural changes occur in olfactory brain regions and the substantia nigra in a group of early-stage PD patients. Using diffusion tensor imaging (DTI) and the University of Pennsylvania Smell Identification Test (UPSIT), we assessed 24 early-stage PD patients (Hoehn and Yahr stage 1 or 2) and 26 healthy controls (HC). We used DTI and a region of interest (ROI) approach to study the microstructure of the left and right anterior olfactory structures (AOS; comprising the olfactory bulbs and anterior end of the olfactory tracts) and the substantia nigra (SN). PD patients had reduced UPSIT scores relative to HC and showed increased mean diffusivity (MD) in the SN, with no lateralized differences. Significant group differences in fractional anisotropy (FA) and MD were seen in the AOS, but these differences were restricted to the right side and were not associated with the primary side of motor symptoms amongst PD patients. No associations were observed between lateralized motor impairment and lateralized microstructural changes in AOS. Impaired olfaction and microstructural changes in AOS are useful for early identification of PD but asymmetries in AOS microstructure seem unrelated to the laterality of PD motor symptoms.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Altinayar S, Oner S, Can S, Kizilay A, Kamisli S, Sarac K (2014) Olfactory dysfunction and its relation olfactory bulb volume in Parkinson’s disease. Eur Rev Med Pharmacol Sci 18(23):3659–3664PubMed Altinayar S, Oner S, Can S, Kizilay A, Kamisli S, Sarac K (2014) Olfactory dysfunction and its relation olfactory bulb volume in Parkinson’s disease. Eur Rev Med Pharmacol Sci 18(23):3659–3664PubMed
2.
Zurück zum Zitat Atik A, Stewart T, Zhang Z (2016) Alpha-synuclein as a biomarker for Parkinson’s disease. Brain Pathol 26(3):410–418CrossRefPubMed Atik A, Stewart T, Zhang Z (2016) Alpha-synuclein as a biomarker for Parkinson’s disease. Brain Pathol 26(3):410–418CrossRefPubMed
3.
Zurück zum Zitat Bahar-Fuchs A, Chételat G, Villemagne VL, Moss S, Pike K, Masters CL, Rowe C, Savage G (2010) Olfactory deficits and amyloid-β burden in Alzheimer’s disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis 22(4):1081–1087CrossRefPubMed Bahar-Fuchs A, Chételat G, Villemagne VL, Moss S, Pike K, Masters CL, Rowe C, Savage G (2010) Olfactory deficits and amyloid-β burden in Alzheimer’s disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis 22(4):1081–1087CrossRefPubMed
4.
Zurück zum Zitat Benedetti B, Charil A, Rovaris M, Judica E, Valsasina P, Sormani MP, Filippi M (2006) Influence of aging on gray and white matter changes assessed by conventional, MT, and DT MRI. Neurology 66(4):535–539CrossRefPubMed Benedetti B, Charil A, Rovaris M, Judica E, Valsasina P, Sormani MP, Filippi M (2006) Influence of aging on gray and white matter changes assessed by conventional, MT, and DT MRI. Neurology 66(4):535–539CrossRefPubMed
5.
Zurück zum Zitat Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson’s disease. Mov Disord 30(12):1600–1611CrossRefPubMed Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson’s disease. Mov Disord 30(12):1600–1611CrossRefPubMed
6.
Zurück zum Zitat Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschi G (2014) Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson’s disease. Mov Disord 29(4):454–462CrossRefPubMedPubMedCentral Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschi G (2014) Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson’s disease. Mov Disord 29(4):454–462CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Braak H, Braak E, Bohl J, Reintjes R (1996) Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer’s disease. Neurosci Lett 210(2):87–90CrossRefPubMed Braak H, Braak E, Bohl J, Reintjes R (1996) Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer’s disease. Neurosci Lett 210(2):87–90CrossRefPubMed
8.
Zurück zum Zitat Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21:2042–2051CrossRefPubMed Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21:2042–2051CrossRefPubMed
9.
Zurück zum Zitat Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211CrossRefPubMed Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211CrossRefPubMed
10.
Zurück zum Zitat Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318(1):121–134CrossRefPubMed Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318(1):121–134CrossRefPubMed
11.
Zurück zum Zitat Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C (2012) Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-Tesla magnetic resonance imaging. Mov Disord 27(8):1019–1025CrossRefPubMed Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C (2012) Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-Tesla magnetic resonance imaging. Mov Disord 27(8):1019–1025CrossRefPubMed
12.
Zurück zum Zitat Brooks DJ, Pavese N (2011) Imaging biomarkers in Parkinson’s disease. Prog Neurobiol 95(4):614–628CrossRefPubMed Brooks DJ, Pavese N (2011) Imaging biomarkers in Parkinson’s disease. Prog Neurobiol 95(4):614–628CrossRefPubMed
13.
Zurück zum Zitat Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL, Fook-Chong S, Yuen Y, Tan EK (2007) Case control study of diffusion tensor imaging in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78(12):1383–1386CrossRefPubMedPubMedCentral Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL, Fook-Chong S, Yuen Y, Tan EK (2007) Case control study of diffusion tensor imaging in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78(12):1383–1386CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M (2014) Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson’s disease and multiple system atrophy. Eur J Radiol 83(3):564–570CrossRefPubMed Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M (2014) Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson’s disease and multiple system atrophy. Eur J Radiol 83(3):564–570CrossRefPubMed
15.
Zurück zum Zitat Del Tredici K, Braak H (2016) Sporadic Parkinson’s disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol 42(1):33–50CrossRefPubMed Del Tredici K, Braak H (2016) Sporadic Parkinson’s disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol 42(1):33–50CrossRefPubMed
16.
Zurück zum Zitat Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46(3):527–552CrossRefPubMed Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46(3):527–552CrossRefPubMed
17.
Zurück zum Zitat Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244CrossRefPubMed Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244CrossRefPubMed
18.
Zurück zum Zitat Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55(2):138–142CrossRefPubMedPubMedCentral Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55(2):138–142CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Djaldetti R, Ziv I, Melamed E (2006) The mystery of motor asymmetry in Parkinson’s disease. Lancet Neurol 5(9):796–802CrossRefPubMed Djaldetti R, Ziv I, Melamed E (2006) The mystery of motor asymmetry in Parkinson’s disease. Lancet Neurol 5(9):796–802CrossRefPubMed
20.
Zurück zum Zitat Fahn S, Elton RL (1987) UPDRS program members. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Florham Park, Macmillan Healthcare Information, pp 153–163 (293–304) Fahn S, Elton RL (1987) UPDRS program members. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Florham Park, Macmillan Healthcare Information, pp 153–163 (293–304)
21.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39CrossRefPubMed Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39CrossRefPubMed
22.
Zurück zum Zitat Good KP, Martzke JS, Milliken HI, Honer WG, Kopala LC (2002) Unirhinal olfactory identification deficits in young male patients with schizophrenia and related disorders: association with impaired memory function. Schizophr Res 56(3):211–223CrossRefPubMed Good KP, Martzke JS, Milliken HI, Honer WG, Kopala LC (2002) Unirhinal olfactory identification deficits in young male patients with schizophrenia and related disorders: association with impaired memory function. Schizophr Res 56(3):211–223CrossRefPubMed
23.
Zurück zum Zitat Hakyemez HA, Veyseller B, Ozer F, Ozben S, Bayraktar GI, Gurbuz D, Cetin S, Yildirim YS (2013) Relationship of olfactory function with olfactory bulbus volume, disease duration and Unified Parkinson’s disease rating scale scores in patients with early stage of idiopathic Parkinson’s disease. J Clin Neurosci 20(10):1469–1470CrossRefPubMed Hakyemez HA, Veyseller B, Ozer F, Ozben S, Bayraktar GI, Gurbuz D, Cetin S, Yildirim YS (2013) Relationship of olfactory function with olfactory bulbus volume, disease duration and Unified Parkinson’s disease rating scale scores in patients with early stage of idiopathic Parkinson’s disease. J Clin Neurosci 20(10):1469–1470CrossRefPubMed
24.
Zurück zum Zitat Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 30 22(6):839–842CrossRef Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 30 22(6):839–842CrossRef
25.
Zurück zum Zitat Hirata FC, Sato JR, Vieira G, Lucato LT, Leite CC, Bor-Seng-Shu E, Pastorello BF, Otaduy MC, Chaim KT, Campanholo KR, Novaes NP, Melo LM, Gonçalves MR, do Nascimento FB, Teixeira MJ, Barbosa ER, Amaro Jr E, Cardoso EF (2016) Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson’s disease: a diagnostic performance study and meta-analysis. Eur Radiol (epub ahead of print) Hirata FC, Sato JR, Vieira G, Lucato LT, Leite CC, Bor-Seng-Shu E, Pastorello BF, Otaduy MC, Chaim KT, Campanholo KR, Novaes NP, Melo LM, Gonçalves MR, do Nascimento FB, Teixeira MJ, Barbosa ER, Amaro Jr E, Cardoso EF (2016) Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson’s disease: a diagnostic performance study and meta-analysis. Eur Radiol (epub ahead of print)
26.
Zurück zum Zitat Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefPubMed Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefPubMed
27.
Zurück zum Zitat Kim HJ, Kim SJ, Kim HS, Choi CG, Kim N, Han S, Jang EH, Chung SJ, Lee CS (2013) Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson’s disease. Neurosci Lett 550:64–68CrossRefPubMed Kim HJ, Kim SJ, Kim HS, Choi CG, Kim N, Han S, Jang EH, Chung SJ, Lee CS (2013) Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson’s disease. Neurosci Lett 550:64–68CrossRefPubMed
28.
Zurück zum Zitat Kim JY, Lee WY, Chung EJ, Dhong HJ (2007) Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson’s disease. Mov Disord 22(11):1563–1566CrossRefPubMed Kim JY, Lee WY, Chung EJ, Dhong HJ (2007) Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson’s disease. Mov Disord 22(11):1563–1566CrossRefPubMed
29.
Zurück zum Zitat Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17:417–423CrossRefPubMed Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17:417–423CrossRefPubMed
30.
Zurück zum Zitat Kempster PA, Gibb WR, Stern GM, Lees AJ (1989) Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 52(1):72–76CrossRefPubMedPubMedCentral Kempster PA, Gibb WR, Stern GM, Lees AJ (1989) Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 52(1):72–76CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors. Nat Rev Neurol 11(11):625–636CrossRefPubMed Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors. Nat Rev Neurol 11(11):625–636CrossRefPubMed
32.
Zurück zum Zitat Lenfeldt N, Hansson W, Larsson A, Nyberg L, Birgander R, Forsgren L (2013) Diffusion tensor imaging and correlations to Parkinson rating scales. J Neurol 260(11):2823–2830CrossRefPubMed Lenfeldt N, Hansson W, Larsson A, Nyberg L, Birgander R, Forsgren L (2013) Diffusion tensor imaging and correlations to Parkinson rating scales. J Neurol 260(11):2823–2830CrossRefPubMed
33.
Zurück zum Zitat Lenfeldt N, Larsson A, Nyberg L, Birgander R, Forsgren L (2015) Fractional anisotropy in the substantia nigra in Parkinson’s disease: a complex picture. Eur J Neurol 22(10):1408–1414CrossRefPubMed Lenfeldt N, Larsson A, Nyberg L, Birgander R, Forsgren L (2015) Fractional anisotropy in the substantia nigra in Parkinson’s disease: a complex picture. Eur J Neurol 22(10):1408–1414CrossRefPubMed
34.
Zurück zum Zitat Li J, Gu C, Zhu L, Zhou Y, Huang H (2016) Changes in olfactory bulb volume in Parkinson’s disease: a systematic review and meta analysis. PLoS One 11(2):e0149286CrossRefPubMedPubMedCentral Li J, Gu C, Zhu L, Zhou Y, Huang H (2016) Changes in olfactory bulb volume in Parkinson’s disease: a systematic review and meta analysis. PLoS One 11(2):e0149286CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Metzler-Baddeley C, O’Sullivan MJ, Bells S, Pasternak O, Jones DK (2012) How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage 59(2):1394–1403CrossRefPubMed Metzler-Baddeley C, O’Sullivan MJ, Bells S, Pasternak O, Jones DK (2012) How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage 59(2):1394–1403CrossRefPubMed
36.
Zurück zum Zitat Mori S, Zhang J (2006) Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51(5):527–539CrossRefPubMed Mori S, Zhang J (2006) Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51(5):527–539CrossRefPubMed
37.
Zurück zum Zitat Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K (2008) Alpha-synuclein pathology in the neostriatum in Parkinson’s disease. Acta Neuropathol 115(4):453–459CrossRefPubMed Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K (2008) Alpha-synuclein pathology in the neostriatum in Parkinson’s disease. Acta Neuropathol 115(4):453–459CrossRefPubMed
38.
Zurück zum Zitat Mueller A, Abolmaali ND, Hakimi AR, Gloeckler T, Herting B, Reichmann H, Hummel T (2005) Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study. J Neural Transm (Vienna) 112(10):1363–1370CrossRef Mueller A, Abolmaali ND, Hakimi AR, Gloeckler T, Herting B, Reichmann H, Hummel T (2005) Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study. J Neural Transm (Vienna) 112(10):1363–1370CrossRef
39.
Zurück zum Zitat Ofori E, Pasternak O, Planetta PJ, Burciu R, Snyder A, Febo M, Golde TE, Okun MS, Vaillancourt DE (2015) Increased free water in the substantia nigra of Parkinson’s disease: a single-site and multi-site study. Neurobiol Aging 36(2):1097–1104CrossRefPubMed Ofori E, Pasternak O, Planetta PJ, Burciu R, Snyder A, Febo M, Golde TE, Okun MS, Vaillancourt DE (2015) Increased free water in the substantia nigra of Parkinson’s disease: a single-site and multi-site study. Neurobiol Aging 36(2):1097–1104CrossRefPubMed
40.
Zurück zum Zitat Olanow CW, Brundin P (2013) Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder? Mov Disord 28(1):31–40CrossRefPubMed Olanow CW, Brundin P (2013) Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder? Mov Disord 28(1):31–40CrossRefPubMed
41.
Zurück zum Zitat Paschen L, Schmidt N, Wolff S, Cnyrim C, van Eimeren T, Zeuner KE, Deuschl G, Witt K (2015) The olfactory bulb volume in patients with idiopathic Parkinson’s disease. Eur J Neurol 22(7):1068–1073CrossRefPubMed Paschen L, Schmidt N, Wolff S, Cnyrim C, van Eimeren T, Zeuner KE, Deuschl G, Witt K (2015) The olfactory bulb volume in patients with idiopathic Parkinson’s disease. Eur J Neurol 22(7):1068–1073CrossRefPubMed
42.
Zurück zum Zitat Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U (2010) Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 133(11):3423–3433CrossRefPubMed Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U (2010) Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 133(11):3423–3433CrossRefPubMed
44.
Zurück zum Zitat Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE (2016) Free-water imaging in Parkinson’s disease and atypical parkinsonism. Brain 139(Pt 2):495–508CrossRefPubMed Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE (2016) Free-water imaging in Parkinson’s disease and atypical parkinsonism. Brain 139(Pt 2):495–508CrossRefPubMed
45.
Zurück zum Zitat Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12(11):622–634CrossRefPubMed Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12(11):622–634CrossRefPubMed
46.
Zurück zum Zitat Roalf DR, Turetsky BI, Ozwar K, Balderston CC, Johnson SC, Brensinger CM, Gur RE, Siegel SJ, Moberg PJ (2006) Unirhinal olfactory function in schizophrenia patients and first-degree relatives. J Neuropsychiatr Clin Neurosci 18:389–396CrossRef Roalf DR, Turetsky BI, Ozwar K, Balderston CC, Johnson SC, Brensinger CM, Gur RE, Siegel SJ, Moberg PJ (2006) Unirhinal olfactory function in schizophrenia patients and first-degree relatives. J Neuropsychiatr Clin Neurosci 18:389–396CrossRef
47.
Zurück zum Zitat Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson’s disease. J Neurol 258(7):1254–1260CrossRefPubMed Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson’s disease. J Neurol 258(7):1254–1260CrossRefPubMed
48.
49.
Zurück zum Zitat Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K (2013) Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease. Brain 136(10):3028–3037CrossRefPubMed Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K (2013) Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease. Brain 136(10):3028–3037CrossRefPubMed
50.
Zurück zum Zitat Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129(Pt 2):538–542PubMed Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129(Pt 2):538–542PubMed
51.
Zurück zum Zitat Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP (2013) Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: a region-of-interest and voxel-based study at 3 T and systematic review of meta-analysis. NeuroImage Clin 3:481–488CrossRefPubMedPubMedCentral Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP (2013) Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: a region-of-interest and voxel-based study at 3 T and systematic review of meta-analysis. NeuroImage Clin 3:481–488CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy R, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(S1):208–219CrossRef Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy R, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(S1):208–219CrossRef
53.
Zurück zum Zitat Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. 72(16):1378–1384CrossRefPubMedPubMedCentral Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. 72(16):1378–1384CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Valle-Leija P, Drucker-Colín R (2014) Unilateral olfactory deficit in a hemiparkinson’s disease mouse model. NeuroReport 25(12):948–953CrossRefPubMed Valle-Leija P, Drucker-Colín R (2014) Unilateral olfactory deficit in a hemiparkinson’s disease mouse model. NeuroReport 25(12):948–953CrossRefPubMed
55.
Zurück zum Zitat Wang J, Yang QX, Sun X, Vesek J, Mosher Z, Vasavada M, Chu J, Kanekar S, Shivkumar V, Venkiteswaran K, Subramanian T (2015) MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson’s disease. Parkinsonsim Relat Disord 21:590–596CrossRef Wang J, Yang QX, Sun X, Vesek J, Mosher Z, Vasavada M, Chu J, Kanekar S, Shivkumar V, Venkiteswaran K, Subramanian T (2015) MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson’s disease. Parkinsonsim Relat Disord 21:590–596CrossRef
56.
Zurück zum Zitat Zatorre RJ, Jones-Gotman M (1991) Human olfactory discrimination after unilateral frontal or temporal lobectomy. Brain 114:71–84CrossRefPubMed Zatorre RJ, Jones-Gotman M (1991) Human olfactory discrimination after unilateral frontal or temporal lobectomy. Brain 114:71–84CrossRefPubMed
57.
Zurück zum Zitat Zucco GM, Rovatti F, Stevenson RJ (2015) Olfactory asymmetric dysfunction in early Parkinson patients affected by unilateral disorder. Front Psychol 6:1020CrossRefPubMedPubMedCentral Zucco GM, Rovatti F, Stevenson RJ (2015) Olfactory asymmetric dysfunction in early Parkinson patients affected by unilateral disorder. Front Psychol 6:1020CrossRefPubMedPubMedCentral
Metadaten
Titel
Lateralized microstructural changes in early-stage Parkinson’s disease in anterior olfactory structures, but not in substantia nigra
verfasst von
N. Joshi
T. M. Rolheiser
J. D. Fisk
J. R. McKelvey
K. Schoffer
G. Phillips
M. Armstrong
M. N. Khan
R. A. Leslie
B. Rusak
H. A. Robertson
K. P. Good
Publikationsdatum
26.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 7/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8555-3

Weitere Artikel der Ausgabe 7/2017

Journal of Neurology 7/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.